{
      "brief_title": [
            "study",
            "evaluate",
            "safety",
            "tolerability",
            "efficacy",
            "investigational",
            "drug",
            "dietary",
            "supplement",
            "men",
            "postmenopausal",
            "woman",
            "osteoporosis"
      ],
      "brief_summary": [
            "purpose",
            "study",
            "test",
            "safety",
            "tolerability",
            "effectiveness",
            "investigational",
            "drug",
            "dietary",
            "supplement",
            "reduce",
            "risk",
            "vitamin",
            "insufficiency",
            "deficiency",
            "treatment",
            "osteoporosis",
            "men",
            "postmenopausal",
            "woman"
      ],
      "condition": [
            "deficiency"
      ],
      "intervention_type": [
            "Drug"
      ],
      "intervention_name": [
            "MK0217A, alendronate sodium (+) cholecalciferol / Duration of Treatment: 15 weeks"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "men",
            "postmenopausal",
            "woman",
            "osteoporotic",
            "exclusion",
            "criterion",
            "vitamin",
            "deficiency",
            "disease",
            "bone",
            "mineral",
            "metabolism",
            "digestive",
            "disease",
            "cause",
            "malabsorption",
            "significant",
            "medical",
            "condition",
            "adequately",
            "treat"
      ],
      "gender": "All",
      "minimum_age": [
            "40",
            "year"
      ],
      "maximum_age": [
            "90",
            "year"
      ],
      "healthy_volunteers": "No",
      "mesh_term": [
            "deficiency"
      ],
      "id": "NCT00092066"
}